Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection

被引:156
|
作者
Thorburn, K. [1 ]
机构
[1] Royal Liverpool Childrens Hosp, Dept Paediat Intens Care, Liverpool L12 2AP, Merseyside, England
关键词
VIRAL-INFECTION; US CHILDREN; MORTALITY; BRONCHIOLITIS; INFANTS; INFLUENZA;
D O I
10.1136/adc.2008.139188
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: 600 000 deaths worldwide are estimated to be directly or indirectly attributable to respiratory syncytial virus (RSV). Objectives: To determine: ( 1) the mortality rate; and ( 2) risk factors for death in children with severe RSV infection. Setting: 20-bed, regional, multidisciplinary, tertiary, paediatric intensive care unit (PICU) in a university-affiliated children's hospital. Methods: Cohort study of all children with severe RSV infection covering eight consecutive RSV seasons (1999-2007), using PICU admission as a marker of severity. Results: Of the 406 RSV-positive patients that were admitted to PICU: 98.5% required mechanical ventilation; 35 children died-median age 5.1 months (interquartile range (IQR) 2.4-13.6), length of PICU stay 16 days ( IQR 8-31) and 371 survived-median age 2.5 months ( IQR 1.2-9), length of PICU stay 5 days ( IQR 4-9). The overall PICU RSV mortality was 8.6% with a standardised mortality ratio of 0.76. During the study period 2009 RSV-positive patients were admitted to the children's hospital, giving a hospital RSV mortality rate of 1.7%. Of the deaths, 18 were directly RSV related ( RSV bronchiolitis-related mortality PICU 4.4% and hospital 0.9%) as the patients were still RSV positive when they died and 17 children died from non-pneumonitis causes after becoming RSV negative. All of the RSV deaths had pre-existing medical conditions -chromosomal abnormalities 29%, cardiac lesions 27%, neuromuscular 15%, chronic lung disease 12%, large airway abnormality 9%, and immunodeficiency 9%. Nineteen children (56%) had pre-existing disease in two or more organ systems ( relative risk (RR) 4.38). Predisposing risk factors for death were pre-existing disease ( RR 2.36), cardiac anomaly ( RR 2.98) and nosocomial/hospital-acquired RSV infection ( RR 2.89). There is an interaction effect between pre-existing disease, nosocomial/hospital-acquired RSV infection and mortality ( p < 0.001). Conclusions: Pre-existing disease/comorbidity, in particular multiple pre-existing diseases and cardiac anomaly, is associated with a significantly higher risk of death from severe RSV infection. Nosocomial/hospital-acquired RSV infection is an additional major risk factor for death in children with severe RSV infection.
引用
收藏
页码:99 / 103
页数:5
相关论文
共 50 条
  • [11] Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand
    Aikphaibul, Puneyavee
    Theerawit, Tuangtip
    Sophonphan, Jiratchaya
    Wacharachaisurapol, Noppadol
    Jitrungruengnij, Nattapong
    Puthanakit, Thanyawee
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2021, 15 (01) : 64 - 71
  • [12] Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease
    Paul A. Checchia
    Bosco Paes
    Louis Bont
    Paolo Manzoni
    Eric A. F. Simões
    Brigitte Fauroux
    Josep Figueras-Aloy
    Xavier Carbonell-Estrany
    Infectious Diseases and Therapy, 2017, 6 : 37 - 56
  • [13] Clara cell protein 10 polymorphism is not associated with severe respiratory syncytial virus infection*
    Overodder, Henrik
    Naver, Lars
    ACTA PAEDIATRICA, 2012, 101 (01) : 34 - 37
  • [14] Risk factors associated with severe disease in respiratory syncytial virus infected children under 5 years of age
    Havdal, Lise Beier
    Boas, Hakon
    Bekkevold, Terese
    Kran, Anne-Marte Bakken
    Rojahn, Astrid Elisabeth
    Stordal, Ketil
    Debes, Sara
    Dollner, Henrik
    Nordbo, Svein Arne
    Barstad, Bjorn
    Haarr, Elisebet
    Fernandez, Liliana Vazquez
    Nakstad, Britt
    Inchley, Christopher
    Flem, Elmira
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [15] Manifestations and Risk Factors in Children Hospitalized with Respiratory Syncytial Virus Infection
    Kuczborska, Karolina
    Rustecka, Agnieszka
    Wawrzyniak, Agata
    Bedzichowska, Agata
    Kalicki, Boleslaw
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2021, 9 (02): : 1 - 9
  • [16] Definition of erythroid cell-positive blood transcriptome phenotypes associated with severe respiratory syncytial virus infection
    Rinchai, Darawan
    Altman, Matthew C.
    Konza, Oceane
    Hassler, Signe
    Martina, Federica
    Toufiq, Mohammed
    Garand, Mathieu
    Kabeer, Basirudeen Syed Ahamed
    Palucka, Karolina
    Mejias, Asuncion
    Ramilo, Octavio
    Bedognetti, Davide
    Mariotti-Ferrandiz, Encarnita
    Klatzmann, David
    Chaussabel, Damien
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (08):
  • [17] Risk of mortality associated with respiratory syncytial virus and influenza infection in adults
    Yong Shik Kwon
    Sun Hyo Park
    Mi-Ae Kim
    Hyun Jung Kim
    Jae Seok Park
    Mi Young Lee
    Choong Won Lee
    Sonila Dauti
    Won-Il Choi
    BMC Infectious Diseases, 17
  • [18] Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection
    Schmidt, Megan E.
    Meyerholz, David K.
    Varga, Steven M.
    MUCOSAL IMMUNOLOGY, 2020, 13 (03) : 507 - 517
  • [19] Clinical and epidemiological impact of respiratory syncytial virus and identification of risk factors for severe disease in children hospitalized due to acute respiratory tract infection
    Ferolla, Fausto M.
    Soffe, Judith
    Mistchenko, Alicia
    Contrini, Maria M.
    Lopez, Eduardo L.
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2019, 117 (04): : 216 - 223
  • [20] All Infants Are at Risk of Developing Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection and Deserve Protection
    Hodges, Erin N.
    White, Meghan
    Nelson, Christopher B.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (SUPPL 2): : S148 - S153